Go BACK

OUH STUDIES

Studies currently being run within Oxford University Hospitals NHS Foundation Trust.

Showing 641 - 650 of 763 studies

PREDICT – Psoriatic arthritis Recognising Early Disease Indicators Conferring Treatment response. A pilot study to identify biomarkers to predict biologic response in patients with Psoriatic Arthritis commencing a second or third biologic drug

VIVO Biobank (VIVO Biobank)

Producing a novel Symptom Burden Scale for people living with Idiopathic Multicentric Castleman Disease (ISBUS)

Development Of A CT Radiomics Approach To Assess Perivascular Fat Modification And To Predict Blood Pressure Response After Renal Artery Denervation: The Molten Study

SCN1A Horizons: A natural history study of SCN1A-related epilepsies in the United Kingdom (SCN1A Horizons)

LUNA (CP-MGC026-01) - A Phase 1/1b, First-in-Human, Open Label, Dose Escalation and Cohort Expansion Study of MGC026 in Participants with Advanced Solid Tumors (LUNA)

Paediatric Intracranial Hypertension: Monitoring intracranial pressure using ophthalmological imagin (PICMO)

Longitudinal Magnetic Resonance Imaging (MRI) Study of 11-18 Year Olds with Traumatic Brain Injury

Cancer and neoplasms

A Phase 1/2, Open-label, Dose-escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Oral TP-3654 in Patients with Intermediate or High-risk Primary or Secondary Myelofibrosis

Oral and Gastrointestinal

A Multicenter, Open-label, Long-term, Safety, Tolerability, and Efficacy Study of XEN1101 in Subjects Diagnosed With Epilepsy (XPF-010-304 (X-TOLE4))